Valiant Laboratories (Small Cap) Share Target 2024, 2025 To 2039
|
Valiant Laboratories Limited |
|||
|
Price: ₹113.83 | ||
| 52 Week Low: ₹100.20 52 Week High: ₹214.95 |
|||
| Market Capital: 645.88 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Valiant Laboratories Share Price Target For 2024
- 1.1.1: Valiant Laboratories Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Valiant Laboratories Share Price Target For 2025
- 1.2.1: Valiant Laboratories Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Valiant Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Valiant Laboratories Brief Company Overview
- 4: Valiant Laboratories Financial Performance
- 4.0.1: Is Valiant Laboratories A Good Buy For Long Term?
To predict the Valiant Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Valiant Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Valiant Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Valiant Laboratories shares in 2024, see the table below.
Valiant Laboratories Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 119.51 (+4.98%) | Price Action: 18 Sep 2024 Low |
| 2024 Target 2 | 118.27 (+3.9%) | Price Action: 11 Oct 2024 High |
| 2024 Target 1 | 116.95 (+2.74%) | Price Action: 23 Dec 2024 High |
| Current Price | 113.83 | Valiant Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 112.33 (-1.32%) | Price Action: 09 Oct 2024 Low |
| Stop Loss 2 | 111.11 (-2.39%) | Price Action: 21 Oct 2024 Low |
| Stop Loss 3 | 109.8 (-3.55%) | Price Action: 19 Aug 2024 High |
Short-Term Technical Outlook
Current Technical Position: Valiant Laboratories is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹114.56 serves as the nearest technical reference point.
Historical Returns: 3-month: -5.63% | 6-month: -17.98% | 1-year: -34.28%
Valiant Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Valiant Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Valiant Laboratories shares in 2025, see the table below.
Valiant Laboratories Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 186.9 (+64.19%) | Price Action: 16 Nov 2023 Low |
| 2025 Target 2 | 185.0 (+62.52%) | Price Action: 19 Dec 2023 High |
| 2025 Target 1 | 183.0 (+60.76%) | Price Action: 15 Nov 2023 Low |
| Current Price | 113.83 | Valiant Laboratories's share price as of 26 Dec 2024 |
| Stop Loss 1 | 95.69 (-15.94%) | Price Action: Chart |
| Stop Loss 2 | 94.73 (-16.78%) | Price Action: Chart |
| Stop Loss 3 | 93.02 (-18.29%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Valiant Laboratories is currently trading near its 52-week low of ₹100.2, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -34.28% | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Valiant Laboratories Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹113.83 | ||
| 2024 | ₹91.90 | -19.26% | ₹98.90 |
| 2025 | ₹84.91 | -7.6% | ₹86.18 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Valiant Laboratories Brief Company Overview
Company Overview: Valiant Laboratories Limited Valiant Laboratories Limited is an Indian-based pharmaceutical company that produces and markets a wide range of active pharmaceutical ingredients (APIs) and bulk drugs for the treatment of various illnesses. Key...
product: Paracetamol in different grades for treating headaches, pain, and fever. Also manufactures: Specialty chemicals. Founded: 1980 Headquarters: Mumbai, India Subsidiary of: Dhanvallabh Ventures LLP Valiant Laboratories is committed to providing high-quality products and services to its customers worldwide.Valiant Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 645.88 Crore | Market valuation of Valiant Laboratories's shares. |
| Revenue (TTM) | 409.69 Crore | Total revenue generated by Valiant Laboratories over the past twelve months. |
| Net Income (TTM) | +25.64 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -16.79% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +6.25% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-42.8% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
57.66 | Company's total debt divided by total shareholder equity. |
| Total Debt | 60.87 Crore | Sum of Valiant Laboratories's current & long-term financial obligations. |
| Total Cash | 19.23 Crore | Total amount of liquid funds available to Valiant Laboratories. |
Is Valiant Laboratories A Good Buy For Long Term?
Valiant Laboratories, with a market cap of 645.88 Cr., has a history of stagnant returns. Despite a revenue of 409.69 Cr. and a net profit of 25.64 Cr. in the past year, the recent -42.8% quarterly revenue decline and low profit margin of 6.25% indicate challenges. Its debt of 60.87 Cr. warrants caution. Given the company's performance and financial position, it may not be a compelling buy for long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
